We are an international biotech company committed to our goal of improving the lives of patients through innovative and differentiated antibody therapeutics.read more
Brad Bailey — Executive Vice President and Chief Commercial Officer at Genmab
Executive Bio
Mr. Bailey joined Genmab in 2020 and became Executive Vice President and Chief Commercial Officer effective August 19, 2024. Mr. Bailey leads Genmab’s commercial organization globally and is responsible for driving growth across the company’s portfolio and delivering its antibody-based medicines to patients.
In his prior role as Senior Vice President and General Manager of the United States, Mr. Bailey established the company’s commercial organization in the US and led the launches of Genmab’s first two marketed medicines.
With more than 25 years in the healthcare industry, Mr. Bailey has extensive experience in strategic and operational commercial leadership roles across specialty biopharma, oncology, immunology, and other serious diseases in the US and around the world.
He holds a Bachelor of Science in Business Administration from Clemson University.
Executive Team Culture Ratings from Genmab Employees
TOP
30%
Genmab's Executive Team scores in the Top 30% of similar sized companies on Comparably